PRECISIONvalue is an MM&M finalist!
We're excited to announce that PRECISIONvalue has been shortlisted for a 2020 MM&M award along with Takeda Oncology in the Use of Market Access Marketing category!
IDNs and Employers Are Seeking Savings By Cutting Out Health Insurer ‘Middlemen’
Precision's Avi Mamidi discusses the benefits and obstacles of cutting out health insurance middlemen and moving towards direct partnerships between Integrated Delivery Networks (IDNs) and employers.
Could the COVID-19 Pandemic Create New Opportunities for the Adoption of APMs and Be a Catalyst for the Movement From Volume to Value?
Precision's Elizabeth Oyekan identifies four emerging trends in alternative payment models (APM) practices that are enabling APMs to be better prepared to deliver high-quality and more affordable care during the COVID-19 pandemic.
Virtual Pharma-Payer Negotiations May Require More Persistence in COVID-19 Era
Precision's Andrew Cournoyer discusses our research results on the effects of the shift to virtual negotiations between pharma and payers as a result of the COVID-19 pandemic, and the challenges they face going forward.
PRECISIONvalue has made the list again!
Congratulations to the team for being listed as one of the top healthcare agencies of 2020 by MedAd News!
